Home
Clinical Trials
About Us
Company Overview
Board of Directors
Senior Management
Corporate Directory
Corporate Governance
Lead Candidate
Overview
Clinical Trials
Completed Trials
Microparticle Platform
Publications
Investor Information
Welcome
Investor Fact Sheet
Research
Top 20 Shareholders
Key Dates
Capital Structure
Shareholder Services
Investor FAQs
News & Reports
ASX Announcements
Annual Reports
Media Coverage
Presentations
Patient and Media Reports
Email Alerts
Finance News Network Interviews
Contact Us
Contact Us
Email Alerts
Innate Immunotherapeutics Limited
Home
>
News & Reports
>
Patient and Media Reports
>
Print Page
Patient and Media Reports
MSTranslate interviews patient as part of a MIS416 Clinical Trial special feature
The video below is one of a series of interviews carried out by MSTranslate. MSTranslate is an independent, curated multiple sclerosis information resource. MSTranslate have recently posted a feature on their website in relation to the Company's MIS416 clinical program for patients with secondary progressive multiple sclerosis (SPMS). The feature includes video interviews with the Company's Managing Director and the Chief Scientific Officer and with patients who have been accessing MIS416 on compassionate grounds in New Zealand. Click here to view this feature on the MSTranslate website
Your browser does not support the video tag.
Channel 7 Perth - SPMS Trial
Your browser does not support the video tag.
Patients with Secondary Progressive Multiple Sclerosis (SPMS) talk about MIS416
Biotech Nation
ASX Announcements
Annual Reports
Media Coverage
Presentations
Patient and Media Reports
Email Alerts
Finance News Network Interviews